234 related articles for article (PubMed ID: 29922930)
21. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic adenocarcinomas without secondary signs on multiphasic multidetector CT: association with clinical and histopathologic features.
Tamada T; Ito K; Kanomata N; Sone T; Kanki A; Higaki A; Hayashida M; Yamamoto A
Eur Radiol; 2016 Mar; 26(3):646-55. PubMed ID: 26084602
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma.
Cheng CS; Liu W; Zhou L; Tang W; Zhong A; Meng Z; Chen L; Chen Z
Biomed Res Int; 2019; 2019():1356264. PubMed ID: 31886169
[TBL] [Abstract][Full Text] [Related]
24. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer.
Yamashita Y; Ueda K; Itonaga M; Yoshida T; Maeda H; Maekita T; Iguchi M; Tamai H; Ichinose M; Kato J
Pancreas; 2013 Aug; 42(6):990-5. PubMed ID: 23851433
[TBL] [Abstract][Full Text] [Related]
25. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.
Hamidian Jahromi A; Sangster G; Zibari G; Martin B; Chu Q; Takalkar A; Shi R; Shokouh-Amiri H
JOP; 2013 Jul; 14(4):466-8. PubMed ID: 23846950
[TBL] [Abstract][Full Text] [Related]
27. A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis.
Kai K; Hiyoshi M; Imamura N; Hamada T; Yano K; Sato Y; Sakae T; Komi M; Nakamura T; Choijookhuu N; Hishikawa Y; Nanashima A
Intern Med; 2023; 62(8):1107-1115. PubMed ID: 37062714
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of preoperative fluorodeoxyglucose positron emission tomography/computed tomography in patients with potentially resectable pancreatic cancer.
Omiya Y; Ichikawa S; Satoh Y; Motosugi U; Nakajima N; Onishi H
Abdom Radiol (NY); 2018 Dec; 43(12):3381-3389. PubMed ID: 30043215
[TBL] [Abstract][Full Text] [Related]
29. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
30. Extracellular volume fraction derived from equilibrium contrast-enhanced CT as a diagnostic parameter in anterior mediastinal tumors.
Takumi K; Nagano H; Oose A; Gohara M; Kamimura K; Nakajo M; Harada-Takeda A; Ueda K; Tabata K; Yoshiura T
Eur J Radiol; 2023 Aug; 165():110891. PubMed ID: 37245341
[TBL] [Abstract][Full Text] [Related]
31. Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy.
Cai W; Zhu Y; Teng Z; Li D; Cong R; Chen Z; Ma X; Zhao X
Insights Imaging; 2024 May; 15(1):116. PubMed ID: 38735009
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction.
Sato A; Nozato T; Hikita H; Akiyama D; Nishina H; Hoshi T; Aihara H; Kakefuda Y; Watabe H; Hiroe M; Aonuma K
J Am Coll Cardiol; 2012 Feb; 59(8):730-8. PubMed ID: 22340265
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM
Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of new subtraction algorithm in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine liver CT protocol equilibrium phase data: Preliminary experience.
Shinagawa Y; Sakamoto K; Sato K; Ito E; Urakawa H; Yoshimitsu K
Eur J Radiol; 2018 Jun; 103():99-104. PubMed ID: 29803393
[TBL] [Abstract][Full Text] [Related]
35. Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging.
Lee HJ; Im DJ; Youn JC; Chang S; Suh YJ; Hong YJ; Kim YJ; Hur J; Choi BW
Radiology; 2016 Jul; 280(1):49-57. PubMed ID: 27322972
[TBL] [Abstract][Full Text] [Related]
36. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings.
Bandula S; White SK; Flett AS; Lawrence D; Pugliese F; Ashworth MT; Punwani S; Taylor SA; Moon JC
Radiology; 2013 Nov; 269(2):396-403. PubMed ID: 23878282
[TBL] [Abstract][Full Text] [Related]
37. The extracellular volume fraction of the pancreas measured by dual-energy computed tomography: The association with impaired glucose tolerance.
Kameda F; Tanabe M; Higashi M; Ariyoshi S; Ihara K; Iida E; Furukawa M; Okada M; Ito K
Eur J Radiol; 2021 Aug; 141():109775. PubMed ID: 34020172
[TBL] [Abstract][Full Text] [Related]
38. Extracellular volume fraction of the pancreas predicts glucose intolerance in patients undergoing major pancreatic surgeries.
Zhu L; Wang S; Sun Z; Liu J; Dai M; Han X; Xu Q; Li N; Dominik Nickel M; Xue H; Jin Z
Eur J Radiol; 2023 Jul; 164():110859. PubMed ID: 37172440
[TBL] [Abstract][Full Text] [Related]
39. Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer.
Usón Junior PLS; Callegaro-Filho D; Bugano DDG; Moura F; Maluf FC
J Gastrointest Cancer; 2018 Dec; 49(4):481-486. PubMed ID: 28924968
[TBL] [Abstract][Full Text] [Related]
40. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
